Login to Your Account



Biogen shares dip on Tecfidera sales, PML report

By Michael Fitzhugh
Staff Writer

Wednesday, October 22, 2014

Biogen Idec Inc. shares (NASDAQ:BIIB) sunk 5.4 percent Wednesday to $309.07 despite third quarter net earnings of $857 million, or $3.62 per diluted share, up 76 percent from last year's third quarter.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription